1.
JCO Precis Oncol
; 8: e2400154, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38885453
RESUMO
ALK-rearranged RCC refractory to several lines of treatment has a durable response when treated with alectinib.